Estimating SARS‐CoV‐2 Omicron XBB.1.5 Spike‐Directed Functional Antibody Levels From an Anti‐Receptor Binding Domain Wuhan‐Hu‐1‐Based Commercial Immunoassay Results

Documenti analoghi

• Neutralizing Antibody and T‐Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1‐Adapted mRNA COVID‐19 Vaccine in Immunosuppressed and Healthy Individuals
  di: Ángela Sánchez‐Simarro, et al.
  Pubblicazione: (2025)
• Dynamics of SARS‐CoV‐2 Spike Receptor‐Binding Domain‐Targeted Specific Peripheral Memory B Cells in Patients With End‐Stage Chronic Kidney Disease Undergoing Replacement Therapy Following COVID‐19 Vaccination
  di: Ángela Sánchez‐Simarro, et al.
  Pubblicazione: (2025)
• Deep Sequencing Reveals Dual Evolution of SARS‐CoV‐2: Insights Into Defective Genomes From Wuhan‐Hu‐1 Variants to Omicron Subvariants
  di: Carolina Campos, et al.
  Pubblicazione: (2025)
• Correction to “Deep Sequencing Reveals Dual Evolution of SARS‐CoV‐2: Insights Into Defective Genomes From Wuhan‐Hu‐1 Variants to Omicron Subvariants”
  Pubblicazione: (2026)
• Cytomegalovirus IL‐10 in Plasma as a Marker of Active Infection in Allogeneic Hematopoietic Transplant Recipients: An Exploratory Study
  di: Ángela Sánchez‐Simarro, et al.
  Pubblicazione: (2026)